Research
We spent years building this technology in the lab, InstaNovo and the ecosystem that grew out of it, before bringing it to companies and researchers.
Publications
Nature Communications
2026Extends de novo sequencing to phosphorylated peptides, one of the modification-heavy settings where database-driven interpretation loses the most ground.
Read the paper →Molecular & Cellular Proteomics
2026An end-to-end approach to reading full proteins that lack a genomic reference, the case that matters most for antibodies, venoms and engineered sequences.
Read the paper →arXiv
2025 · PreprintThe confidence layer: rescoring de novo predictions and estimating false discovery rates, so results can be filtered at a threshold that means something.
Read the preprint →Nature Machine Intelligence
2025Introduces the transformer and diffusion-based de novo sequencing models at the core of the platform, and demonstrates peptide identification at the scale of real proteomics experiments without a reference database.
Read the paper →If you want to run Seqora against your own data, or talk through any of this in detail, get in touch.